Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Yoshifumi Miura, MD"'
Autor:
Yoshifumi Miura, MD, Hiroshi Noguchi, MD, PhD, Yasuhiro Okabe, MD, Kosuke Masutani, MD, PhD, Shoji Tokunaga, PhD, Masafumi Nakamura, MD, PhD
Publikováno v:
Transplantation Direct, Vol 5, Iss 2, p e423 (2019)
Background. The risk of cardiovascular events remains after kidney transplantation (KT). Abnormal glucose metabolism and hyperlipidemia contribute partly to this risk. Among angiotensin II type-1 receptor blockers, telmisartan alone has been shown to
Externí odkaz:
https://doaj.org/article/ab89e0a4a5964d1f96095421d956d5bb
